Zealand Pharma’s US$1 Billion Equity Offering

DLA Piper acted as US counsel to Zealand Pharma on the offering.Zealand Pharma, a Danish biotechnology company focused on the discovery and development of peptide-based medicines,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here